When Maxim Budyansky, MSE ’11, and Neil Shah, MSE ’11, entered the yearlong David E. Swirnow Master of Science in Bioengineering and Design Program, they knew they felt passionate about medicine and engineering. But they had no particular idea where those passions would lead them. The answer turned out to be deep into the cancellous, or […]
Pratik Patel, Kevin Colbert and Michael Parlato are the founders of Glyscend, Inc., a startup with the ambitious goal of disrupting the treatment landscape for type 2 diabetes mellitus (T2DM). T2DM is one of the most prevalent diseases in the United States, with over 20 million diagnosed patients, approximately 8 million undiagnosed, and an additional […]
Keenahan and Budman’s startup company, Tissue Analytics, is transforming the smartphone into a sophisticated platform for imaging and remotely evaluating chronic wounds. The 8.5 million Americans living with chronic wounds, such as bedsores and diabetic ulcers, cost the US healthcare system $30 billion each year. The high cost of care is a result of two […]
